Skip to content

Our Partners



Montreal Heart Institute (MHI)

The Montreal Heart Institute is home to the Canada’s largest cardiology research centre, cardiovascular prevention and cardiovascular genetics centres. The Institute is affiliated with the Université de Montréal.

The Montreal Health Innovations Coordinating Center (MHICC) is a leading academic clinical research organization and an integral part of the Montreal Heart Institute (MHI).

Established in 2008, the Beaulieu-Saucier Pharmacogenomics Centre is an academic organization dedicated to the advance of knowledge and promoting discoveries in precision medicine by leading high quality pharmacogenomics research in partnership with industry, governmental and academic organizations.

The Montreal Heart Institute Foundation raises and administers funds to support research, care, teaching, prevention, rehabilitation, and the assessment of new technologies at the Montreal Heart Institute

Ecogène-21, a not-for-profit (NPO) clinical research organization dedicated to access innovation for unmet medical needs, coordinated from the Saguenay–Lac-Saint-Jean region. ECOGENE-21 has a solid experience and world-renowned expertise in the design, conduct and management of clinical trials, as well as the valorization of innovations designed to promote access to precision medicine with novel, safe, efficacious and affordable treatments.

The Centre of Excellence on Partnerships with Patients and the Public (CEPPP) of Université de Montréal (at the Centre de recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM)) is the largest centre focused on patient partnerships in Canada.

Located within the McGill Genome Centre, the Centre of Genomics and Policy (CGP) works at the crossroads of law, medicine, and public policy. Applying a multidisciplinary perspective and collaborating with national and international partners, the CGP analyzes the socio-ethical and legal norms influencing the promotion, prevention and protection of human health.

The Quebec Research Group in Chronic Myeloid Leukemia and Myeloproliferative Neoplasia is a non-profit organization (NPO) created in 2011 with the objective of improving the management of certain hematological cancers by facilitating the linking of experts in the field (hematologists, pharmacists, nurses, scientists, etc.) to patients registered in pan-Quebec hematological cancer registries.

The CMDO Research Network aims to develop research in cardiometabolic health, diabetes and obesity, to translate knowledge and to promote evidence for improving the health and quality of life of Quebecers.

Polytechnique is more than an educational establishment – it is the benchmark in engineering, with high-quality teaching and research activities that continually push the limits of knowledge.

Hospitals and CIUSSS

Information Technologies In Health And Artificial Intelligence (AI)

Perceiv is a precision medicine company unlocking the potential of medical data and deep learning (artificial intelligence) to optimize diagnosis and prognosis.

The only electronic medical record (EMR) that connects all healthcare stakeholders Family business. Young since 1984. Designed by and for doctors.

Kelvin Zero is a new approach to data, identity, and authentication. We have developed a revolutionary technology that allows critical organizations to easily share data access without ever sharing the data itself. Protect privacy. Minimize risk. Secure data.

Noze is the global leader in digital smell detection. Using technology built on a foundation of NASA-patented innovations deployed on the International Space Station, Noze created the world’s first and only digital nose that can detect, identify and interpret odors in everyday environments with incredible accuracy.

We produce and tailor biomedical research instruments for pre-clinical and clinical research.

Biopharmaceutical, Biotechnology And Investment Companies

InvHealth Capital Inc. (InvHealth) invests in business opportunities exclusively in the field of healthcare and with a favourable socio-economic balance. With constant rising healthcare costs, good science and clinical data alone are not enough: A successful and financially rewarding medical solution also has to be practical and affordable for the patients / payers.

Pharmaceutical Research that Brings Tangible and Affordable Medical Solutions. We are committed to helping patients who are suffering from serious and debilitating illness by advancing tangible and affordable treatments addressing unmet medical needs.

Rénibus Therapeutics® Inc. is a biotech company dedicated to transforming the cardio-renal disease treatment paradigm by focusing on the prevention and treatment of kidney disease.

Pioneering Precision Medicine for Cardiovascular Disease.  DalCor is a biopharmaceutical company focused on addressing cardiovascular disease, the greatest global healthcare burden.


We transform the world of diagnostics by seeing the invisible. Optinaʼs platform combines all the power of a state-of-the-art camera with artificial intelligence (AI). Our innovative technology analyzes the retina, looking for subtle changes that can provide valuable data on different diseases.

Inogen’s mission is to improve the quality of life of patients on supplemental oxygen.